ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,597Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 387

$792K Total Retail Price of All Prescriptions

Rank: 52 out of 387

683 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 683 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 683 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 14,825 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 648 571 1 2
LISINOPRIL 568 509 2 3
HYDROCODONE-ACETAMINOPHEN 567 492 S3 3 1
OMEPRAZOLE 497 471 4 4
SIMVASTATIN 464 433 5 5
METOPROLOL TARTRATE 457 387 6 11
FUROSEMIDE 427 404 7 7
AMLODIPINE BESYLATE 424 395 8 6
GABAPENTIN 345 300 9 10
METFORMIN HCL 341 320 10 8
PRAVASTATIN SODIUM 332 270 11 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 295 278 12 30
ATENOLOL 279 247 13 20
ATORVASTATIN CALCIUM 269 244 14 13
TRAMADOL HCL 267 233 15 14
ZOLPIDEM TARTRATE 258 240 16 16
CARVEDILOL 246 229 17 21
AMLODIPINE BESYLATE-BENAZEPRIL 231 231 18 54
POTASSIUM CHLORIDE 226 214 19 9
HYDROCHLOROTHIAZIDE 208 171 20 12
METOPROLOL SUCCINATE 201 191 21 18
CITALOPRAM HBR 166 135 22 19
SERTRALINE HCL 148 114 23 23
ALENDRONATE SODIUM 148 145 23 31
RANITIDINE HCL 136 118 25 45
SPIRONOLACTONE 135 125 26 67
LOVASTATIN 133 130 27 36
DIGOXIN 132 132 28 40
FLUTICASONE PROPIONATE 130 107 29 29
NEXIUM 129 117 30 26
FLUOXETINE HCL 123 116 31 46
CYCLOBENZAPRINE HCL 122 92 R 32 42
DIOVAN 119 108 33 33
LANTUS 109 94 34 51
TAMSULOSIN HCL 107 98 35 32
WARFARIN SODIUM 107 98 35 17
LOSARTAN POTASSIUM 105 99 37 24
GLIPIZIDE 98 98 38 63
PAROXETINE HCL 93 93 39 52
ADVAIR DISKUS 93 67 39 41
DIOVAN HCT 92 91 41 74
FELODIPINE ER 91 91 42 130
TRAZODONE HCL 88 70 43 37
DONEPEZIL HCL 85 83 44 27
CLONIDINE HCL 82 73 45 38
PROAIR HFA 80 65 46 47
MIRTAZAPINE 77 62 47 64
PREDNISONE 76 64 48 43
FINASTERIDE 76 76 48 95
EXFORGE 76 76 48 157
TRIAMTERENE-HCTZ 72 71 51 55
AMITRIPTYLINE HCL 71 50 R 52 62
SPIRIVA 70 65 53 61
SPIRONOLACTONE-HCTZ 70 70 53 330
LYRICA 70 57 53 66
ALLOPURINOL 70 59 53 28
CLOPIDOGREL 68 68 57 25
ESTRADIOL 66 60 R 58 105
CRESTOR 65 62 59 34
LOSARTAN-HYDROCHLOROTHIAZIDE 65 65 59 65
VERAPAMIL ER 64 64 61 87
NOVOLOG 64 56 61 116
BENAZEPRIL HCL 63 63 63 86
BISOPROLOL-HYDROCHLOROTHIAZIDE 63 63 63 144
CYMBALTA 63 48 63 44
PREMARIN 62 59 R 66 77
AZITHROMYCIN 58 51 67 49
BUPROPION HCL SR 58 43 67 158
PROPRANOLOL HCL 58 42 67 100
VENLAFAXINE HCL ER 55 34 70 97
PLAVIX 55 55 70 39
PROMETHAZINE HCL 54 36 R 72 82
MELOXICAM 53 52 73 22
GLIPIZIDE XL 53 43 73 232
JANUVIA 53 40 73 60
FAMOTIDINE 52 48 76 78
NAMENDA 51 51 77 35
ESCITALOPRAM OXALATE 50 33 78 73
DOXYCYCLINE HYCLATE 50 44 78 114
LIPITOR 50 38 78 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.